Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons.
Morphine stimulates the internalization of mu-opioid receptors (MORs) in transfected cell models to a lesser degree than opioid peptides and other analgesic drugs, such as methadone, and previous studies have reported that morphine does not produce a detectable redistribution of MORs in neural tissue after either acute or chronic administration. Nevertheless, morphine produces profound physiological effects, raising the question of whether receptor trafficking plays any role in the in vivo actions of morphine. We investigated the effects of opiate drugs on recombinant and native opioid receptors in the nucleus accumbens, which plays an important role in mediating the behavioral effects of opiate drugs. Morphine and methadone differed in their effects on the internalization of epitope-tagged MORs in cell bodies, introduced by viral gene transfer and imaged by fluorescence microscopy. A mutation of the cytoplasmic tail that confers morphine-induced internalization in cultured cells had a similar effect on receptor trafficking in nucleus accumbens cell bodies. Surprisingly, in contrast to its failure to affect MOR distribution detectably in cell bodies, acute morphine administration produced a pronounced change in MOR distribution visualized in the processes of the same neurons. A similar effect of acute morphine administration was observed for endogenously expressed MORs by immunoelectron microscopy; the acute administration of morphine increased the density of MORs associated with internal membrane structures specifically in dendrites. These results provide the first evidence that morphine regulates the distribution of MORs in neuronal processes, suggesting that "compartment-selective" membrane trafficking represents a previously unanticipated type of opioid receptor regulation contributing to the in vivo effects of opiate drugs on a physiologically relevant population of CNS neurons.
Haberstock-Debic
Helena
H
Department of Psychiatry, University of California, San Francisco, San Francisco, California 94143-2140, USA.
Wein
Marc
M
Barrot
Michel
M
Colago
Eric E O
EE
Rahman
Zia
Z
Neve
Rachael L
RL
Pickel
Virginia M
VM
Nestler
Eric J
EJ
von Zastrow
Mark
M
Svingos
Adena L
AL
D000818:Animals; D003712:Dendrites / Q000187:drug effects* / Q000378:metabolism* / Q000502:physiology / Q000648:ultrastructure; D004705:Endocytosis / Q000187:drug effects / Q000502:physiology; D005822:Genetic Vectors / Q000235:genetics; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism; D008691:Methadone / Q000008:administration & dosage / Q000494:pharmacology; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D009154:Mutation; D009474:Neurons / Q000737:chemistry / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D009714:Nucleus Accumbens / Q000737:chemistry / Q000187:drug effects* / Q000648:ultrastructure / Q000821:virology; D021381:Protein Transport / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017465:Receptors, Opioid, delta / Q000819:agonists / Q000235:genetics / Q000378:metabolism* / Q000648:ultrastructure; D017450:Receptors, Opioid, mu / Q000819:agonists / Q000235:genetics / Q000378:metabolism* / Q000648:ultrastructure; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D018139:Simplexvirus / Q000235:genetics
D008565:Membrane Proteins; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu; D011994:Recombinant Proteins; D009020:Morphine; D008691:Methadone